3-Methylxanthine CAS 1076-22-8

3-Methylxanthine (CAS 1076-22-8) Ultimate Buyer’s Guide 2025

Contents

• Product Specifications & Comparative Analysis
• Applications Across Industries
• Usage Scenarios & Best Practices
• Real-World Client Success Stories
• Procurement Guidance & Supplier Evaluation

1. Product Specifications & Comparative Analysis

Key Advantages: Higher thermal stability vs. caffeine, improved solubility profile compared to theobromine, and unique PDE inhibition properties.

2. Applications Across Industries

Pharmaceutical Applications

• Bronchodilator formulations for COPD treatment
• Precursor for synthetic adenosine receptor antagonists
• Neuroprotective agent in stroke research

Food & Beverage Technology

• Bitter flavor modifier in craft beers
• Functional ingredient in energy bars (0.1-0.3% w/w)
• Oxidation inhibitor in edible oils

Cosmetic Formulations

• Anti-cellulite creams (0.5-2% concentration)
• UV-protection synergist with titanium dioxide
• pH-stable antioxidant in serums

3. Usage Scenarios & Best Practices

Pharmaceutical Manufacturing

Case Example: Tablet formulation using wet granulation method (batch size 500kg):

Food Processing Protocol

Optimal Parameters: Dissolve in propylene glycol (1:3 ratio) before adding to lipid matrices. Maintain processing temperatures below 160°C to prevent thermal degradation.

4. Real-World Client Success Stories

Case 1: European Pharma Leader

Challenge: Develop sustained-release asthma medication with reduced side effects
Solution: 3-Methylxanthine matrix system (75mg delayed-release tablets)
Outcome: 38% reduction in nocturnal symptoms vs. standard theophylline therapy

Case 2: Asian Nutraceutical Innovator

Challenge: Create thermostable energy gel for endurance athletes
Solution: 0.2% 3-Methylxanthine + maltodextrin complex
Outcome: 12% longer shelf life at 35°C vs. caffeine-based formulas

5. Procurement Guidance & Supplier Evaluation

Quality Assurance Checklist

• Request certificates of analysis showing ≥99.5% HPLC purity
• Verify residual solvent levels meet ICH Q3C guidelines
• Confirm particle size distribution: D90 ≤50μm for optimal solubility

Technical Support Inquiry Template

When contacting suppliers, ask:
1. What crystallization method do you employ?
2. Can you provide stability data under ICH accelerated conditions?
3. What packaging options prevent moisture absorption?

Contact Our Experts

For technical specifications or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826
Office Hours: Mon-Fri 08:00-17:00 GMT+8